In silico enhancer mining reveals SNS-032 and EHMT2 inhibitors as therapeutic candidates in high-grade serous ovarian cancer.
- DOI
- 10.1038/s41416-023-02274-2
- Published
- 2023 Jul
- Container
- British journal of cancer
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1038/s41416-023-02274-2,
title = {In silico enhancer mining reveals SNS-032 and EHMT2 inhibitors as therapeutic candidates in high-grade serous ovarian cancer.},
author = {Quintela M and James DW and Garcia J and Edwards K and Margarit L and Das N and Lutchman-Singh K and Beynon AL and Rioja I and Prinjha RK and Harker NR and Gonzalez D and Steven Conlan R and Francis LW},
year = {2023},
journal = {British journal of cancer},
doi = {10.1038/s41416-023-02274-2},
url = {https://doi.org/10.1038/s41416-023-02274-2}
}RIS
TY - JOUR TI - In silico enhancer mining reveals SNS-032 and EHMT2 inhibitors as therapeutic candidates in high-grade serous ovarian cancer. AU - Quintela M AU - James DW AU - Garcia J AU - Edwards K AU - Margarit L AU - Das N AU - Lutchman-Singh K AU - Beynon AL AU - Rioja I AU - Prinjha RK AU - Harker NR AU - Gonzalez D AU - Steven Conlan R AU - Francis LW PY - 2023 JO - British journal of cancer DO - 10.1038/s41416-023-02274-2 UR - https://doi.org/10.1038/s41416-023-02274-2 ER -
APA
M, Q., DW, J., J, G., K, E., L, M., N, D., K, L., AL, B., I, R., RK, P., NR, H., D, G., R, S. C., & LW, F. (2023). In silico enhancer mining reveals SNS-032 and EHMT2 inhibitors as therapeutic candidates in high-grade serous ovarian cancer.. British journal of cancer. https://doi.org/10.1038/s41416-023-02274-2
Source records
- pubmed · retrieved 2026-09-27T10:32:39.631Z